Hydroxyethanediphosphonic acid
Hydroxyethanediphosphonic acid Brand names, Hydroxyethanediphosphonic acid Analogs
- Acetodiphosphonic acid
- Acide etidronique [INN-French]
- Acido etidronico [INN-Spanish]
- Acidum etidronicum [INN-Latin]
- Cintichem Technetium 99m Hedspa
- Dequest 2010
- Dequest 2015
- Dequest Z 010
- Didronel
- Didronel IV
- EHDP
- Etidronate Disodium
- Etidronic acid
- Etidronic acid [USAN:BAN:INN]
- Etidronsaeure
- Ferrofos 510
- HEDP
- Hydroxyethanediphosphonic acid
- MPI Stannous Diphosphonate
- Osteoscan
- Oxyethylidenediphosphonic acid
- Turpinal SL
Hydroxyethanediphosphonic acid Brand Names Mixture
- No information avaliable
Hydroxyethanediphosphonic acid Chemical_Formula
C24H25NO4
Hydroxyethanediphosphonic acid RX_link
http://www.rxlist.com/cgi/generic3/flavoxate.htm
Hydroxyethanediphosphonic acid fda sheet
Hydroxyethanediphosphonic acid msds (material safety sheet)
Hydroxyethanediphosphonic acid Synthesis Reference
No information avaliable
Hydroxyethanediphosphonic acid Molecular Weight
391.46 g/mol
Hydroxyethanediphosphonic acid Melting Point
No information avaliable
Hydroxyethanediphosphonic acid H2O Solubility
10 mg/L
Hydroxyethanediphosphonic acid State
Solid
Hydroxyethanediphosphonic acid LogP
4.636
Hydroxyethanediphosphonic acid Dosage Forms
Tablets (100 mg)
Hydroxyethanediphosphonic acid Indication
For symptomatic relief of dysuria, urgency, nocturia, suprapubic pain, frequency and incontinence as may occur in cystitis, prostatitis, urethritis, urethrocystitis/urethrotrigonitis.
Hydroxyethanediphosphonic acid Pharmacology
Flavoxate is a spasmolytic flavone derivative that acts by relaxing the smooth muscle in the urinary tract. Flavoxate is a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. Muscarinic receptors play an important role in several major cholin-ergically mediated functions, including contractions of urinary bladder smooth muscle and stimulation of salivary secretion.
Hydroxyethanediphosphonic acid Absorption
Well absorbed from gastrointestinal tract.
Hydroxyethanediphosphonic acid side effects and Toxicity
The oral LD50 for flavoxate HCl in rats is 4273 mg/kg. The oral LD50 for flavoxate HCl in mice is 1837 mg/kg. Symptoms of overdose include convulsions, decreased ability to sweat, (warm, red skin, dry mouth, and increased body temperature), hallucinations, increased heart rate and blood pressure, and mental confusion.
Hydroxyethanediphosphonic acid Patient Information
Hydroxyethanediphosphonic acid Organisms Affected
Humans and other mammals
